MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.
Journal article
Webster RG. et al, (2026), Proc Natl Acad Sci U S A, 123
Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention
Journal article
AHMED A., (2026), Nature Communications
CREP: Cis-Regulatory Element Predictor Based on Fine-Tuned Enformer
Preprint
Stranieri N. et al, (2026)
Learning quality scores for chromatin accessibility bigWig tracks using Machine Learning
Preprint
Sanders E. et al, (2026)